The First AI-Native Operating System for Evidence & Value
Powered by Claude Opus 4.5 and Gemini 3.0 Pro. Frontier AI that already knows HEOR, competitive intelligence, and market access—built so a two-person team can deliver what used to take an army of consultants.
E&V Teams Are Running on Empty
Smart people doing important work with terrible infrastructure. We built the platform to fix it.
Budget Reality
Consultant budgets cut 40%. Headcount frozen. Board still wants Big Pharma deliverables from a team that can fit in a sedan.
AI Markup
Your consultants are using Claude behind the scenes—and billing $500/hour for outputs that took them 20 minutes.
Tool Sprawl
The average P&MA team uses 11.3 disconnected tools. Your strategy lives in Excel, PowerPoint, Salesforce, and six browser tabs.
Groundhog Day
You've explained your TPP to three different consulting teams this year. Each one charged $75K to get up to speed.
One Platform. Frontier AI. Zero Learning Curve.
ValOracle combines everything your market access team needs in one integrated system. Intelligence flows into strategy, strategy informs modeling, modeling drives execution.
I spent 23 years watching brilliant people do important work with terrible infrastructure. We built the platform I wish existed when I was in the trenches—one that actually understands the work.
Everything You Need, Connected
Six integrated modules covering the full market access lifecycle—from competitive intelligence through launch execution.
HEOR Modeling
Build models in hours, not weeks. Run PSA in seconds, not overnight. Validated CEA, BIM, and PartSA with cloud-based Monte Carlo.
Intelligence Engine
See the whole board. Move before competitors know they're behind. AI-powered HTA monitoring, trial tracking, and RAG-powered document intelligence.
Strategy Workbench
From TPP to payer conversation—one connected workflow. Digital TPP builder, evidence gap analysis, value story architect, and GVD authoring.
Pricing Engine
See the cascade before it happens. Price with confidence. IRP simulation, GTN waterfall analysis, and multi-year forecasting with erosion modeling.
US Payer Intelligence
Know every payer's rules before you walk into the room. 40+ health plan profiles with formulary tracking, coverage policies, and payer archetypes.
Execution Tracker
From strategy to launch day—nothing falls through the cracks. Launch playbooks, milestone tracking, stakeholder mapping, and KPI dashboards.
Frontier AI That Already Knows E&V
No generic chatbots. No endless prompting. Just AI that understands market access from Day 1.
No Prompting Required
ValOracle's AI understands P&MA and HEOR context from your first interaction. Ask about IRP cascades, payer archetypes, or evidence gaps—it speaks your language immediately.
Matches or Exceeds Specialist Performance
Powered by Claude Opus 4.5 and Gemini 3.0 Pro—frontier AI models that routinely match or exceed specialist performance on analytical tasks.
Pharma-Grade Security
SOC 2 Type II compliant. HIPAA-eligible. Your competitive intelligence and pricing data never trains public models.
The AI will argue with you about your positioning—and be right half the time.
Not Another Tool. The Right Platform.
See how ValOracle compares to the alternatives you're already considering—and why integration beats patchwork every time.
Pay for Insight, Not Infrastructure
"We bring strategic expertise"
Consultants are great for strategic thinking. But do you really need to pay $50K for a deck that recycles the same HEOR frameworks? ValOracle doesn't replace your strategic advisors—it gives your internal team the tools to do 80% of the work themselves.
Domain Expertise, Not Just Dashboards
"We can visualize anything"
You can visualize data. We generate insights. Your team isn't drowning because they can't make charts—they're drowning because they're manually tracking 6 HTA agencies, building BIMs in Excel, and copying competitor pipelines into PowerPoint.
Integration Is the Value
"We're best-in-class at one thing"
Sure, you can buy a clinical trial tracker, a separate HTA monitoring tool, build your own BIM template, and hire a consultant for your value story. Or have one system where competitive intelligence informs your economic model, connects to your TPP, and feeds your GVD.
See What's Possible
Real teams. Real constraints. Real results.
The Skeleton Crew's Secret Weapon
A 2-person P&MA team. Phase 3 data dropping in 6 weeks. No consultants in the budget.
Full strategy playbook, evidence gap analysis, payer value story, and launch sequencing model—all due before the board meeting.
18 days. $230K in avoided consultant spend. Board approved the launch strategy unanimously.
The Evidence Deadline
NICE submission in 6 weeks. Then a competitor published negative ICER results.
Complete competitive analysis, positioning pivot, and updated BIM—without a $200K emergency consulting engagement.
PSA dropped from 4 hours to 12 minutes. Positioning pivot completed in 3 days. Submission went out on time.
The Intelligence Race
A CI team spending 10+ hours/week on manual monitoring.
Keep up with global HTA decisions, competitor pipeline moves, and payer policy changes—with a team of one.
ValOracle's Research Agent spotted a competitor's FDA submission 3 weeks before their press release.
Trusted by Market Access Leaders
Hear from the professionals who've transformed their workflows with ValOracle.
"ValOracle replaced three separate tools and saved our HEOR team 20 hours a week. The integrated workflow is exactly what we needed."
"The HTA monitoring alone paid for the platform in the first quarter. We never miss a decision that matters to our portfolio now."
"We finally have a single source of truth for our market access strategy. The sensitivity analysis that used to take days now takes minutes."
Ready to See What AI-Native E&V Looks Like?
30 minutes. No slides. Just the platform solving real E&V problems.
"We built the platform I wish I'd had when I was selling these frameworks as a consultant." — Ethan Cole, Founder